Coverage and reimbursement decisions are hardly predictable or consistent within and across US payers. Payers are in the position of determining which drugs to pay for, for whom, and at what level to ...

The Opportunities and Challenges of Rethinking Our Approach to Value Assessment in Healthcare As America’s healthcare system continues to evolve, it is critical that our perception of care and its ...

The production cost and the need to pursue quality control initiatives are seen as the major triggers of a make-or-buy decision analysis in procurement. SUPPLY chain management is an area where the ...